Cargando…

Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis

INTRODUCTION: Infection with Epstein-Barr virus (EBV) has been suggested to contribute to the pathogenesis of autoimmune diseases, including rheumatoid arthritis (RA). We sought to determine whether prior infection with the virus occurs more frequently in patients with RA compared to controls. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ball, Robert J., Avenell, Alison, Aucott, Lorna, Hanlon, Peter, Vickers, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587583/
https://www.ncbi.nlm.nih.gov/pubmed/26416719
http://dx.doi.org/10.1186/s13075-015-0755-6
_version_ 1782392491774836736
author Ball, Robert J.
Avenell, Alison
Aucott, Lorna
Hanlon, Peter
Vickers, Mark A.
author_facet Ball, Robert J.
Avenell, Alison
Aucott, Lorna
Hanlon, Peter
Vickers, Mark A.
author_sort Ball, Robert J.
collection PubMed
description INTRODUCTION: Infection with Epstein-Barr virus (EBV) has been suggested to contribute to the pathogenesis of autoimmune diseases, including rheumatoid arthritis (RA). We sought to determine whether prior infection with the virus occurs more frequently in patients with RA compared to controls. METHODS: We performed a systematic review and meta-analyses of studies that reported the prevalence of anti-EBV antibodies in the sera of cases with RA and controls by searching Medline and Embase databases from 1946 to 2014, with no language restriction. Mantel-Haenszel odds ratios for the detection of anti-EBV antibodies were calculated, and meta-analyses conducted. Quality assessments were performed using a modified version of the Newcastle-Ottawa scale. RESULTS: Twenty-three studies were included. Quality assessment found most studies reported acceptable selection criteria but poor descriptions of how cases and controls were recruited. When all studies were included, there was a statistically significant higher seroprevalence of anti-VCA IgG in patients with RA compared to controls with an odds ratio (OR) of 1.61 (95 % confidence interval (CI) 1.05–2.46, p = 0.03), which is a similar-sized summary OR to that reported for systemic lupus erythematosus (SLE). However, when studies were restricted to those reporting more plausible levels of exposure to EBV in the control groups, no significant association was apparent, OR 1.47 (95 % CI 0.88–2.46, p = 0.14). Using anti-EBNA 1 or anti-EA IgG as markers of previous infection also did not yield significant associations (OR 1.05, 95 % CI 0.68–1.61, p = 0.82; OR 2.2, 95 % CI 0.86–5.65, p = 0.10 respectively). CONCLUSIONS: Overall, these findings do not demonstrate an association between EBV seroprevalence and RA and therefore do not support the hypothesis that prior infection with EBV predisposes to the development of RA. This contrasts with meta-analyses that indicate EBV infection is associated with multiple sclerosis and SLE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0755-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4587583
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45875832015-09-30 Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis Ball, Robert J. Avenell, Alison Aucott, Lorna Hanlon, Peter Vickers, Mark A. Arthritis Res Ther Research Article INTRODUCTION: Infection with Epstein-Barr virus (EBV) has been suggested to contribute to the pathogenesis of autoimmune diseases, including rheumatoid arthritis (RA). We sought to determine whether prior infection with the virus occurs more frequently in patients with RA compared to controls. METHODS: We performed a systematic review and meta-analyses of studies that reported the prevalence of anti-EBV antibodies in the sera of cases with RA and controls by searching Medline and Embase databases from 1946 to 2014, with no language restriction. Mantel-Haenszel odds ratios for the detection of anti-EBV antibodies were calculated, and meta-analyses conducted. Quality assessments were performed using a modified version of the Newcastle-Ottawa scale. RESULTS: Twenty-three studies were included. Quality assessment found most studies reported acceptable selection criteria but poor descriptions of how cases and controls were recruited. When all studies were included, there was a statistically significant higher seroprevalence of anti-VCA IgG in patients with RA compared to controls with an odds ratio (OR) of 1.61 (95 % confidence interval (CI) 1.05–2.46, p = 0.03), which is a similar-sized summary OR to that reported for systemic lupus erythematosus (SLE). However, when studies were restricted to those reporting more plausible levels of exposure to EBV in the control groups, no significant association was apparent, OR 1.47 (95 % CI 0.88–2.46, p = 0.14). Using anti-EBNA 1 or anti-EA IgG as markers of previous infection also did not yield significant associations (OR 1.05, 95 % CI 0.68–1.61, p = 0.82; OR 2.2, 95 % CI 0.86–5.65, p = 0.10 respectively). CONCLUSIONS: Overall, these findings do not demonstrate an association between EBV seroprevalence and RA and therefore do not support the hypothesis that prior infection with EBV predisposes to the development of RA. This contrasts with meta-analyses that indicate EBV infection is associated with multiple sclerosis and SLE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-015-0755-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-29 2015 /pmc/articles/PMC4587583/ /pubmed/26416719 http://dx.doi.org/10.1186/s13075-015-0755-6 Text en © Ball et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ball, Robert J.
Avenell, Alison
Aucott, Lorna
Hanlon, Peter
Vickers, Mark A.
Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title_full Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title_fullStr Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title_full_unstemmed Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title_short Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis
title_sort systematic review and meta-analysis of the sero-epidemiological association between epstein-barr virus and rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587583/
https://www.ncbi.nlm.nih.gov/pubmed/26416719
http://dx.doi.org/10.1186/s13075-015-0755-6
work_keys_str_mv AT ballrobertj systematicreviewandmetaanalysisoftheseroepidemiologicalassociationbetweenepsteinbarrvirusandrheumatoidarthritis
AT avenellalison systematicreviewandmetaanalysisoftheseroepidemiologicalassociationbetweenepsteinbarrvirusandrheumatoidarthritis
AT aucottlorna systematicreviewandmetaanalysisoftheseroepidemiologicalassociationbetweenepsteinbarrvirusandrheumatoidarthritis
AT hanlonpeter systematicreviewandmetaanalysisoftheseroepidemiologicalassociationbetweenepsteinbarrvirusandrheumatoidarthritis
AT vickersmarka systematicreviewandmetaanalysisoftheseroepidemiologicalassociationbetweenepsteinbarrvirusandrheumatoidarthritis